2015
DOI: 10.1002/anie.201507546
|View full text |Cite
|
Sign up to set email alerts
|

A High‐Throughput Platform for Formulating and Screening Multifunctional Nanoparticles Capable of Simultaneous Delivery of Genes and Transcription Factors

Abstract: Simultaneous delivery of multiple genes and proteins (e.g., transcription factors, TFs) is an emerging issue surrounding therapeutic research due to their ability to regulate cellular circuitry. Current gene and protein delivery strategies, however, are based on slow batch synthesis, which is ineffective, poorly controlled, and incapable of simultaneous delivery of both genes and proteins with synergistic functions. Consequently, advances in this field have been limited to in vitro studies. Here, by integratin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 39 publications
(14 citation statements)
references
References 42 publications
0
14
0
Order By: Relevance
“…However, conventional batch processes by bulk mixing and nanoprecipitation are technically challenging in fabricating monodisperse nanoparticles with a desired size and morphology, which compromises the properties of the produced nanoparticles [146]. Microfluidic systems have opened a new horizon for the development of novel nanoparticles as drug carriers [147, 148]. The rapid and tunable mixing in microfluidics makes it capable for precious control over the synthesis processes of nanoparticles by systematically varying parameters such as flow rates, reagent concentrations and compositions, temperature, and mixture time.…”
Section: Integration Of Drug Carriers In Microfluidic Platformsmentioning
confidence: 99%
“…However, conventional batch processes by bulk mixing and nanoprecipitation are technically challenging in fabricating monodisperse nanoparticles with a desired size and morphology, which compromises the properties of the produced nanoparticles [146]. Microfluidic systems have opened a new horizon for the development of novel nanoparticles as drug carriers [147, 148]. The rapid and tunable mixing in microfluidics makes it capable for precious control over the synthesis processes of nanoparticles by systematically varying parameters such as flow rates, reagent concentrations and compositions, temperature, and mixture time.…”
Section: Integration Of Drug Carriers In Microfluidic Platformsmentioning
confidence: 99%
“…However, it remains challenging to accurately encode the synthetic parameters of each microdroplet, thus limiting the further increasement of its throughput. Recently, a novel high-throughput method called “droplet library”, which combines a microfluidic droplet generator with microarrays, are proposed [ 75 , 113 ]. The basic principles are shown in Figure 5 .…”
Section: Conclusion and Prospectivementioning
confidence: 99%
“…For emerging new applications, such as synthesis of personalized medicine, which only requires small amount of products, the slow production rate of current microfluidic HF reactors can be sufficient. However, considering the ever-growing potential of NPs in industrial applications, and to realize the translation of microfluidic devices for more general biomedical and pharmaceutical applications, it is important to scale-up the synthesis process while maintaining the advantages of microfluidics in order to achieve mass production [66,67]. …”
Section: Scale-up For Mass Productionmentioning
confidence: 99%